# OnCo record paper-aall1331-brown-jama-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-aall1331-brown-jama-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-aall1331-brown-jama-2021" ;
  schema:name "AALL1331: blinatumomab versus chemotherapy consolidation in high- and intermediate-risk first relapse of childhood B-ALL"@en ;
  schema:description "Children whose leukaemia relapsed did better when two cycles of the antibody blinatumomab replaced intensive chemotherapy before transplant: more were alive two years later and far fewer had serious infections, although the disease-free survival difference did not reach the trial's statistical threshold."@en ;
  schema:url <https://onco.cc/key-papers/paper-aall1331-brown-jama-2021/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jama.2021.0669>, <https://pubmed.ncbi.nlm.nih.gov/33651090/> ;
  schema:sameAs <https://doi.org/10.1001/jama.2021.0669> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Brown PA, Ji L, Xu X, et al." ;
  onco:cancers <https://onco.cc/cancers/all-paediatric-relapsed/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:drugs <https://onco.cc/drugs/blinatumomab/> ;
  onco:trials <https://onco.cc/trials/aall1331/> ;
  onco:journals <https://onco.cc/journals/jama/> .